Clinical Trial

Biomarkers of Acute Organ Injury in Pediatric Newly Diagnosed Type 1 Diabetes

Recruiting
View on ClinicalTrials.gov →
Summary
Diabetic ketoacidosis (DKA) is a severe metabolic complication in children with newly diagnosed type 1 diabetes mellitus (T1DM) and may be associated with early injury of vital organs such as the kidneys and the heart. Early detection of organ dysfunction is important for identifying children at increased risk for complications. This observational cross-sectional study aims to evaluate biomarkers of acute organ injury and associated clinical and echocardiographic parameters in children with newly diagnosed T1DM presenting with DKA, compared with children with newly diagnosed T1DM without DKA and healthy controls. Biomarkers including KIM-1, NGAL, high-sensitivity troponin, NT-proBNP, interleukin-6, and C-reactive protein will be measured during hospital admission and within the first 24-48 hours of hospitalization.
Trial Details
NCT Number NCT07483879
Lead Sponsor Aristotle University Of Thessaloniki
Conditions Type 1 Diabetes Mellitus, Diabetic Ketoacidosis
Enrollment 45 participants
Start Date 2025-06-13
Primary Completion 2029-12 (estimated)
Study Completion 2030-03 (estimated)
Updated on ClinicalTrials.gov 2026-03-19